Den endelige individuelle dosis må ikke være mere end to tabletter, men den kan justeres, hvis en patient bliver ved med at have mere end fire episoder af gennembrudssmerte pr. dag.
The final individual dose must include no more than two tablets, but it can be adjusted if a patient consistently has more than four episodes of breakthrough pain per day.